Peter Laing

City:

Cambridge

Country:

United Kingdom

Published Applications:

Last publication date:

2024-10-17

Top Assignees for applications by Peter Laing

The entities that hold a legal rights for patent applications filed by inventor Laing Peter:

United Therapeutics Corporation 5 Silver Spring, MD United States
Excivion Limited (LTD) 1 Cambridge, United Kingdom
Excivion Ltd. 1 Cambridgeshire, United Kingdom
Cyclolab Cyclodextrin Research and Development Laboratory Ltd. 1 Budapest, Hungary
Excivion LTD 1 Huntingdon, United Kingdom
United Therapeutics Corporation 1 Siver Spring, MD United States
Excivion LTD 1 Willingham, United Kingdom

Recent patent applications by Laing Peter

Peter Laing from Cambridge, GB has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-10-17

US20240343673A1

Chemistry; metallurgy

CONTROLLED RELEASE PHARMACEUTICAL FORMULATIONS

#2 | 2022-05-19

US20220152087A1

Human necessities

CYCLODEXTRIN DERIVATIVES REDUCING FLAVIVIRUS NS1-INDUCED ENDOTHELIAL HYPERPERMEABILITY AND VASCULAR LEAK

#3 | 2021-10-14

US20210317066A1

Chemistry; metallurgy

Controlled release pharmaceutical formulations

#4 | 2020-07-09

US20200215180A1

Human necessities

Glycosylated analogues of Flavivirus E proteins and their use in diagnostic methods

#5 | 2020-02-27

US20200062691A1

Chemistry; metallurgy

Controlled release pharmaceutical formulations

#6 | 2019-10-03

US20190300580A1

Chemistry; metallurgy

Modified flavivirus envelope sequences comprising unique glycosylation sites

#7 | 2017-12-28

US20170369416A1

Chemistry; metallurgy

Controlled release pharmaceutical formulations

#8 | 2014-10-30

US20140323567A1

Chemistry; metallurgy

Controlled release pharmaceutical formulations

#9 | 2009-05-07

US20090117135A1

Chemistry; metallurgy

VACCINE COMPRISING AN ANTIGEN CONJUGATED TO LOW VALENCY ANTI-CD40 OR ANTI-CD28 ANTIBODIES

InventorID:

954506 ⎘